Mechanisms of cancer stem cell therapy
AA Samadani, A Keymoradzdeh, S Shams… - Clinica Chimica …, 2020 - Elsevier
Cancer stem cells (CSCs) are responsible for carcinogenesis and tumorigenesis and are
involved in drug and radiation resistance, metastasis, tumor relapse and initiation …
involved in drug and radiation resistance, metastasis, tumor relapse and initiation …
Antimicrobial peptides: a promising strategy for lung cancer drug discovery?
F Zandsalimi, S Talaei… - Expert Opinion on …, 2020 - Taylor & Francis
ABSTRACT Introduction Antimicrobial peptides (AMPs), also called host defense peptides
(HDPs), are identified in almost any form of life, which play an important role in innate …
(HDPs), are identified in almost any form of life, which play an important role in innate …
[HTML][HTML] The MEK/ERK/miR-21 signaling is critical in osimertinib resistance in EGFR-mutant non-small cell lung cancer cells
Simple Summary Our study provided data that the inhibition of MEK/ERK signaling could
overcome Osimertinib resistance both in vitro and in vivo. Mechanistically, MEK inhibitor …
overcome Osimertinib resistance both in vitro and in vivo. Mechanistically, MEK inhibitor …
[HTML][HTML] Effective drug concentration and selectivity depends on fraction of primitive cells
Poor efficiency of chemotherapeutics in the eradication of Cancer Stem Cells (CSCs) has
been driving the search for more active and specific compounds. In this work, we show how …
been driving the search for more active and specific compounds. In this work, we show how …
[HTML][HTML] The role of extracellular vesicles in non-small-cell lung cancer, the unknowns, and how new approach methodologies can support new knowledge generation …
Extracellular vesicles (EVs) are nanosized particles released from most human cell types
that contain a variety of cargos responsible for mediating cell-to-cell and organ-to-organ …
that contain a variety of cargos responsible for mediating cell-to-cell and organ-to-organ …
Tumor microenvironment of cancer stem cells: Perspectives on cancer stem cell targeting
Q Guo, Y Zhou, T Xie, Y Yuan, H Li, W Shi, L Zheng… - Genes & …, 2023 - Elsevier
There are few tumor cell subpopulations with stem cell characteristics in tumor tissue,
defined as cancer stem cells (CSCs) or cancer stem-like cells (CSLCs), which can …
defined as cancer stem cells (CSCs) or cancer stem-like cells (CSLCs), which can …
[HTML][HTML] MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased …
K Zhu, Z Lv, J Xiong, H Zheng, S Zhang, H Jin… - Aging (Albany …, 2021 - ncbi.nlm.nih.gov
Background: Patients with non-small cell lung cancer (NSCLC) initially responding to
tyrosine kinase inhibitors (TKIs) eventually develop resistance due to accumulating …
tyrosine kinase inhibitors (TKIs) eventually develop resistance due to accumulating …
[HTML][HTML] CD44+/EPCAM+ cells detect a subpopulation of ALDHhigh cells in human non-small cell lung cancer: A chance for targeting cancer stem cells?
V Masciale, G Grisendi, F Banchelli, R D'Amico… - Oncotarget, 2020 - ncbi.nlm.nih.gov
Objectives: Several studies demonstrated that aldehyde dehydrogenase (ALDH) and CD44
are the most considered cancer stem cells (CSC) markers. However, a comparison between …
are the most considered cancer stem cells (CSC) markers. However, a comparison between …
[HTML][HTML] 5-O-Acetyl-Renieramycin T from Blue Sponge Xestospongia sp. Induces Lung Cancer Stem Cell Apoptosis
W Chantarawong, S Chamni, K Suwanborirux, N Saito… - Marine drugs, 2019 - mdpi.com
Lung cancer is one of the most significant cancers as it accounts for almost 1 in 5 cancer
deaths worldwide, with an increasing incident rate. Management of the cancer has been …
deaths worldwide, with an increasing incident rate. Management of the cancer has been …
[HTML][HTML] The synergistic effect of piperlongumine and sanguinarine on the non-small lung cancer
M Hałas-Wiśniewska, W Zielińska, M Izdebska… - Molecules, 2020 - mdpi.com
Background: Cancers are one of the leading causes of deaths nowadays. The development
of new treatment schemes for oncological diseases is an interesting direction in …
of new treatment schemes for oncological diseases is an interesting direction in …